INFOGRAPHIC

North American CDMO Landscape 2024

Exclusive new infographic summarises the main CDMO players operating facilities in North America. 

This infographic summarises the main players with facilities in North America who develop and manufacture Active Pharmaceutical Ingredients, Biologics and Cell & Gene Therapies.

The United States accounts for nearly half of the global pharmaceutical revenues and is the world leader in contract development and manufacturing.

The contract manufacturing market in the United States is expected to reach $68.32 Billion USD by 2029, followed by China, India and Germany. Canada is also a significant market for CDMOs, expected to reach $7.88 Billion.

Despite the size of the North American market, it’s notable that growth forecasts are more modest over the 2023-2028 period than some other markets. The United States is forecast for +4.74% CAGR and Canada for 6.79% CAGR, compared to the higher levels of growth the CDMO market is expected to see from India (+11.34% CAGR) or China (+9.63% CAGR). Source: Mordor Intelligence

North American CDMO Landscape infographic

Download a free high resolution infographic by filling out the short form.

Who are we missing?

While every effort has been made to capture all contract manufacturers in the infographic, we are not yet comprehensive.

About CDMO Live

CDMO Live is the ultimate online partnering event for bio/pharma outsourcing. Join this exclusive  event on 7-8 May 2025 to  discover the latest trends and best practices in contract manufacturing, and connect with leading partners who can accelerate and de-risk your small molecule and biologic projects. 

Register here for your ticket

Download the high resolution infographic

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.